Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (ACTRN12625000828426) titled 'Randomized ControllEd PhaSe-II Clinical TriAl of Methylene Blue veRsus Placebo in Cardiac ArresT (RESTART) Study' on Aug. 1.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Parallel
Primary Sponsor: The Alfred Hospital
Condition:
Cardiac arrest
Cardiac arrest
Cardiovascular - Coronary heart disease
Cardiovascular - Other cardiovascular diseases
Intervention:
Eligible patients will be randomised in a 1:1 fashion to receive EITHER Methylene blue (MeB) or Placebo: The study medication will be administered by a r...